TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo (Q37623535)
Jump to navigation
Jump to search
scientific article published on 09 January 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo |
scientific article published on 09 January 2014 |
Statements
1 reference
TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo (English)
1 reference
Hayley Ma
1 reference
Bao Nguyen
1 reference
Li Li
1 reference
Sarah Greenblatt
1 reference
Allen Williams
1 reference
Ming Zhao
1 reference
Mark Levis
1 reference
Michelle Rudek
1 reference
Amy Duffield
1 reference
Donald Small
1 reference
9 January 2014
1 reference
1 reference
1525-1534
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference